ENG
ESP
Hemophagocytic syndrome: Clinical characterization and follow-up in a Chilean pediatric cohort
Patricio Andres Astudillo Paredes
Published 2021-07-09
Keywords
How to Cite
Copyright (c) 2021 Patricio Andres Astudillo Paredes, Carla Ximena Parejas T, María Angélica Wietstruck Pena, Pamela Morales Matamala, Katia Abarca Villaseca
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: Hemophagocytic lymphohistiocytosis (HLH) is a severe syndrome, potentially lethal, with a pathological activation of the immune system and an extreme hyperinflammatory response. The etiology is classified in primary HLH (familiar or genetic) and secondary (infectious, oncological, and rheumatological diseases). Aim: To analyze clinical and laboratory characteristics, treatment, and follow-up rates in pediatric patients with HLH. Methods: A pediatric cohort of patients with HLH diagnosis attending in a tertiary hospital between January 2000 to February 2019 was analysed. Results: 23 hospitalized patients were recruited with a median of 36 months. The most frequent clinical and laboratory findings were fever, cytopenias, and hyperferritinemia. The most frequent aetiologies were infectious (Epstein Barr virus and citomegalovirus) and rheumatological diseases. The global mortality
3
was 35%, there was no significant difference between etiologies. Discussion: Considering the high mortality of HLH it is very important to have a high grade of suspicion that allows treating at an early stage. It would be important to determine clinical and laboratory predictors in multicentric studies